These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17507161)

  • 21. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.
    Nishihira Y; Tan CF; Onodera O; Toyoshima Y; Yamada M; Morita T; Nishizawa M; Kakita A; Takahashi H
    Acta Neuropathol; 2008 Aug; 116(2):169-82. PubMed ID: 18481073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.
    Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reappraisal of TDP-43 pathology in FTLD-U subtypes.
    Mackenzie IR; Neumann M
    Acta Neuropathol; 2017 Jul; 134(1):79-96. PubMed ID: 28466142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Buratti E; Baralle F; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
    Ann Neurol; 2008 Jul; 64(1):60-70. PubMed ID: 18546284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathological features of sporadic frontotemporal lobar degeneration with TDP-43-positive inclusions].
    Yokota O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1018-21. PubMed ID: 21921551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study.
    Hatanpaa KJ; Bigio EH; Cairns NJ; Womack KB; Weintraub S; Morris JC; Foong C; Xiao G; Hladik C; Mantanona TY; White CL
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):271-9. PubMed ID: 18379440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical entity of frontotemporal dementia with motor neuron disease.
    Mitsuyama Y; Inoue T
    Neuropathology; 2009 Dec; 29(6):649-54. PubMed ID: 19780984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes.
    Josephs KA; Stroh A; Dugger B; Dickson DW
    Acta Neuropathol; 2009 Sep; 118(3):349-58. PubMed ID: 19455346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.
    Mackenzie IR; Baborie A; Pickering-Brown S; Du Plessis D; Jaros E; Perry RH; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2006 Nov; 112(5):539-49. PubMed ID: 17021754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
    Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
    J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.
    Carlos AF; Josephs KA
    J Neurol; 2022 Aug; 269(8):4030-4054. PubMed ID: 35320398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.
    Cairns NJ; Neumann M; Bigio EH; Holm IE; Troost D; Hatanpaa KJ; Foong C; White CL; Schneider JA; Kretzschmar HA; Carter D; Taylor-Reinwald L; Paulsmeyer K; Strider J; Gitcho M; Goate AM; Morris JC; Mishra M; Kwong LK; Stieber A; Xu Y; Forman MS; Trojanowski JQ; Lee VM; Mackenzie IR
    Am J Pathol; 2007 Jul; 171(1):227-40. PubMed ID: 17591968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
    Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
    Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
    Prudlo J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.